Study to Identify the Genetic Variations Associated With Phantom Limb Pain

NCT ID: NCT01462448

Last Updated: 2025-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

726 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-03-31

Study Completion Date

2023-08-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if there is a genetic component to phantom limb pain. DNA will be analyzed for single nucleotide polymorphisms (SNPs) between the control and phantom limb pain group. Total RNA will also be isolated and profiled to asses the degree to which our gene(s) of interest are expressed in the presence or absence of phantom limb pain. Some proteins, such as inflammatory antibodies or the neurotrophin brain-derived neurotrophic factor (BDNF), will also be assessed for their association(s) with phantom limb pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Most patients (90-95%)with major limb amputations experience a phantom limb--the vivid impression that the limb is still present. In many cases, the sensation is painful for reasons that are currently not well understood. A small subset of amputees (\<10%) never experience phantom limb pain (PLP), the painful sensation felt in the amputated limb. This difference suggests that there may be a genetic component that precludes some patients from ever experiencing PLP. Understanding the genetic components of PLP may help in predicting which patients will experience PLP and which amputees will respond to the various treatment options available.

In order to understand the genetic aspects and ultimately develop more effective treatment options in the future, patients with and without PLP will be asked to give 30 mls of blood after overnight fasting. These blood samples will be de-identified and sent to the National Institutes of Health (NIH) in Bethesda, Maryland, where all of the genetic analyses will take place.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Phantom Limb

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Phantom Limb Pain

Subjects will have lower or upper extremity amputation(s) that have resulted in the presence of phantom limb pain.

Blood Draw

Intervention Type PROCEDURE

Single blood draw of 30 ml

No Phantom Limb Pain

Subjects in the group will have a lower or upper extremity amputation(s) without the presence of phantom limb sensation.

Blood Draw

Intervention Type PROCEDURE

Single blood draw of 30 ml

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood Draw

Single blood draw of 30 ml

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Venipuncture

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Chronic PLP Group:

* At least 18 years of age.
* Written informed consent and written authorization for use or release of health and research study information
* Single or multiple upper and/or lower limb amputation
* At least three months post-amputation
* Ability to follow study instructions and likely to complete required visit(s)
* Experienced PLP for at least one month and at least 3 times per week
* Phantom limb pain differentiated from residual limb pain by physical exam.
* Subjects taking blood thinners or other medications that do not increase risk during a blood draw.

Non-Chronic PLP Group:

* At least 18 years of age.
* Written informed consent and written authorization for use or release of health and research study information
* Single or multiple upper and/or lower limb(s) amputation
* At least three months post-amputation
* Ability to follow study instructions and likely to complete required visit(s)
* Experienced PLP less than 10 times total and/or for less than two weeks
* Subjects taking blood thinners or other medications that do not increase risk during a blood draw.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Uniformed Services University of the Health Sciences

FED

Sponsor Role collaborator

Henry M. Jackson Foundation for the Advancement of Military Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul F. Pasquina, MD, MC

Role: PRINCIPAL_INVESTIGATOR

Walter Reed National Military Medical Center (WRNMMC)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Walter Reed National Military Medical Center (WRNMMC)

Bethesda, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Katz J, Melzack R. Pain 'memories' in phantom limbs: review and clinical observations. Pain. 1990 Dec;43(3):319-336. doi: 10.1016/0304-3959(90)90029-D.

Reference Type BACKGROUND
PMID: 2293143 (View on PubMed)

Montoya P, Larbig W, Grulke N, Flor H, Taub E, Birbaumer N. The relationship of phantom limb pain to other phantom limb phenomena in upper extremity amputees. Pain. 1997 Aug;72(1-2):87-93. doi: 10.1016/s0304-3959(97)00004-3.

Reference Type BACKGROUND
PMID: 9272791 (View on PubMed)

Kooijman CM, Dijkstra PU, Geertzen JHB, Elzinga A, van der Schans CP. Phantom pain and phantom sensations in upper limb amputees: an epidemiological study. Pain. 2000 Jul;87(1):33-41. doi: 10.1016/S0304-3959(00)00264-5.

Reference Type BACKGROUND
PMID: 10863043 (View on PubMed)

Ramachandran VS, Hirstein W. The perception of phantom limbs. The D. O. Hebb lecture. Brain. 1998 Sep;121 ( Pt 9):1603-30. doi: 10.1093/brain/121.9.1603.

Reference Type BACKGROUND
PMID: 9762952 (View on PubMed)

Sherman RA, Sherman CJ, Parker L. Chronic phantom and stump pain among American veterans: results of a survey. Pain. 1984 Jan;18(1):83-95. doi: 10.1016/0304-3959(84)90128-3.

Reference Type BACKGROUND
PMID: 6709380 (View on PubMed)

Jensen TS, Krebs B, Nielsen J, Rasmussen P. Phantom limb, phantom pain and stump pain in amputees during the first 6 months following limb amputation. Pain. 1983 Nov;17(3):243-256. doi: 10.1016/0304-3959(83)90097-0.

Reference Type BACKGROUND
PMID: 6657285 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HU0001-11-1-0005

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

20429

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pain Predict Genetics
NCT02383342 RECRUITING
Genetics of Motor Learning
NCT01105845 TERMINATED
Finding Genes for Rare Diseases
NCT02724995 WITHDRAWN